Pricer AB (publ) (PCRBF) Stock Competitors & Peer Comparison
See (PCRBF) competitors and their performances in Stock Market.
Peer Comparison Table: Hardware, Equipment & Parts Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PCRBF | $0.36 | +0.00% | 58.2M | 35.60 | $0.01 | N/A |
| HNHPF | $16.72 | -4.87% | 120.4B | 20.24 | $0.85 | +2.25% |
| KYCCF | $450.50 | -5.56% | 113.6B | 40.90 | $11.45 | +0.76% |
| MRAAY | $27.15 | -6.35% | 108.7B | 74.61 | $0.40 | +0.62% |
| MRAAF | $54.22 | -6.72% | 104.1B | 71.50 | $0.80 | +0.74% |
| VEMLY | $70.45 | -3.41% | 101.3B | 23.02 | $3.06 | +4.27% |
| HNHAF | $3.26 | +0.00% | 45.6B | 9.58 | $0.34 | +6.17% |
| TTDKF | $22.67 | -7.91% | 45.3B | 37.25 | $0.64 | +0.88% |
| TTDKY | $22.47 | -6.27% | 44.5B | 36.60 | $0.64 | +0.80% |
| IBIDF | $101.30 | -12.58% | 31.3B | 83.04 | $1.35 | +0.27% |
Stock Comparison
PCRBF vs HNHPF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, HNHPF has a market cap of 120.4B. Regarding current trading prices, PCRBF is priced at $0.36, while HNHPF trades at $16.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas HNHPF's P/E ratio is 20.24. In terms of profitability, PCRBF's ROE is +0.01%, compared to HNHPF's ROE of +0.12%. Regarding short-term risk, PCRBF is less volatile compared to HNHPF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check HNHPF's competition here
PCRBF vs KYCCF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, KYCCF has a market cap of 113.6B. Regarding current trading prices, PCRBF is priced at $0.36, while KYCCF trades at $450.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas KYCCF's P/E ratio is 40.90. In terms of profitability, PCRBF's ROE is +0.01%, compared to KYCCF's ROE of +0.13%. Regarding short-term risk, PCRBF is less volatile compared to KYCCF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check KYCCF's competition here
PCRBF vs MRAAY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, MRAAY has a market cap of 108.7B. Regarding current trading prices, PCRBF is priced at $0.36, while MRAAY trades at $27.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas MRAAY's P/E ratio is 74.61. In terms of profitability, PCRBF's ROE is +0.01%, compared to MRAAY's ROE of +0.06%. Regarding short-term risk, PCRBF is less volatile compared to MRAAY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check MRAAY's competition here
PCRBF vs MRAAF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, MRAAF has a market cap of 104.1B. Regarding current trading prices, PCRBF is priced at $0.36, while MRAAF trades at $54.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas MRAAF's P/E ratio is 71.50. In terms of profitability, PCRBF's ROE is +0.01%, compared to MRAAF's ROE of +0.09%. Regarding short-term risk, PCRBF is less volatile compared to MRAAF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check MRAAF's competition here
PCRBF vs VEMLY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, VEMLY has a market cap of 101.3B. Regarding current trading prices, PCRBF is priced at $0.36, while VEMLY trades at $70.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas VEMLY's P/E ratio is 23.02. In terms of profitability, PCRBF's ROE is +0.01%, compared to VEMLY's ROE of +0.08%. Regarding short-term risk, PCRBF and VEMLY have similar daily volatility (0.00).Check VEMLY's competition here
PCRBF vs HNHAF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, HNHAF has a market cap of 45.6B. Regarding current trading prices, PCRBF is priced at $0.36, while HNHAF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas HNHAF's P/E ratio is 9.58. In terms of profitability, PCRBF's ROE is +0.01%, compared to HNHAF's ROE of +0.12%. Regarding short-term risk, PCRBF and HNHAF have similar daily volatility (0.00).Check HNHAF's competition here
PCRBF vs TTDKF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, TTDKF has a market cap of 45.3B. Regarding current trading prices, PCRBF is priced at $0.36, while TTDKF trades at $22.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas TTDKF's P/E ratio is 37.25. In terms of profitability, PCRBF's ROE is +0.01%, compared to TTDKF's ROE of +0.10%. Regarding short-term risk, PCRBF and TTDKF have similar daily volatility (0.00).Check TTDKF's competition here
PCRBF vs TTDKY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, TTDKY has a market cap of 44.5B. Regarding current trading prices, PCRBF is priced at $0.36, while TTDKY trades at $22.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas TTDKY's P/E ratio is 36.60. In terms of profitability, PCRBF's ROE is +0.01%, compared to TTDKY's ROE of +0.13%. Regarding short-term risk, PCRBF is less volatile compared to TTDKY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check TTDKY's competition here
PCRBF vs IBIDF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, IBIDF has a market cap of 31.3B. Regarding current trading prices, PCRBF is priced at $0.36, while IBIDF trades at $101.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas IBIDF's P/E ratio is 83.04. In terms of profitability, PCRBF's ROE is +0.01%, compared to IBIDF's ROE of +0.12%. Regarding short-term risk, PCRBF and IBIDF have similar daily volatility (0.00).Check IBIDF's competition here
PCRBF vs HXGBY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, HXGBY has a market cap of 27.2B. Regarding current trading prices, PCRBF is priced at $0.36, while HXGBY trades at $9.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas HXGBY's P/E ratio is 11.53. In terms of profitability, PCRBF's ROE is +0.01%, compared to HXGBY's ROE of +0.19%. Regarding short-term risk, PCRBF is less volatile compared to HXGBY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check HXGBY's competition here
PCRBF vs HXGBF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, HXGBF has a market cap of 22.6B. Regarding current trading prices, PCRBF is priced at $0.36, while HXGBF trades at $8.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas HXGBF's P/E ratio is 9.99. In terms of profitability, PCRBF's ROE is +0.01%, compared to HXGBF's ROE of +0.19%. Regarding short-term risk, PCRBF is less volatile compared to HXGBF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check HXGBF's competition here
PCRBF vs KGBLY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, KGBLY has a market cap of 22.6B. Regarding current trading prices, PCRBF is priced at $0.36, while KGBLY trades at $180.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas KGBLY's P/E ratio is 72.35. In terms of profitability, PCRBF's ROE is +0.01%, compared to KGBLY's ROE of +0.16%. Regarding short-term risk, PCRBF and KGBLY have similar daily volatility (0.00).Check KGBLY's competition here
PCRBF vs TYOYY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, TYOYY has a market cap of 14.2B. Regarding current trading prices, PCRBF is priced at $0.36, while TYOYY trades at $391.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas TYOYY's P/E ratio is 168.50. In terms of profitability, PCRBF's ROE is +0.01%, compared to TYOYY's ROE of +0.05%. Regarding short-term risk, PCRBF is less volatile compared to TYOYY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check TYOYY's competition here
PCRBF vs MNBEF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, MNBEF has a market cap of 11.7B. Regarding current trading prices, PCRBF is priced at $0.36, while MNBEF trades at $26.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas MNBEF's P/E ratio is 18.90. In terms of profitability, PCRBF's ROE is +0.01%, compared to MNBEF's ROE of +0.12%. Regarding short-term risk, PCRBF and MNBEF have similar daily volatility (0.00).Check MNBEF's competition here
PCRBF vs SOTGY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, SOTGY has a market cap of 10.7B. Regarding current trading prices, PCRBF is priced at $0.36, while SOTGY trades at $93.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas SOTGY's P/E ratio is 15.68. In terms of profitability, PCRBF's ROE is +0.01%, compared to SOTGY's ROE of +0.17%. Regarding short-term risk, PCRBF is less volatile compared to SOTGY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check SOTGY's competition here
PCRBF vs ASAAF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, ASAAF has a market cap of 10B. Regarding current trading prices, PCRBF is priced at $0.36, while ASAAF trades at $162.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas ASAAF's P/E ratio is 42.80. In terms of profitability, PCRBF's ROE is +0.01%, compared to ASAAF's ROE of -0.04%. Regarding short-term risk, PCRBF and ASAAF have similar daily volatility (0.00).Check ASAAF's competition here
PCRBF vs BYDIY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, BYDIY has a market cap of 8.3B. Regarding current trading prices, PCRBF is priced at $0.36, while BYDIY trades at $170.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas BYDIY's P/E ratio is 16.05. In terms of profitability, PCRBF's ROE is +0.01%, compared to BYDIY's ROE of +0.10%. Regarding short-term risk, PCRBF is less volatile compared to BYDIY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check BYDIY's competition here
PCRBF vs MNBEY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, MNBEY has a market cap of 7.8B. Regarding current trading prices, PCRBF is priced at $0.36, while MNBEY trades at $38.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas MNBEY's P/E ratio is 17.59. In terms of profitability, PCRBF's ROE is +0.01%, compared to MNBEY's ROE of +0.04%. Regarding short-term risk, PCRBF and MNBEY have similar daily volatility (0.00).Check MNBEY's competition here
PCRBF vs BYDIF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, BYDIF has a market cap of 7.7B. Regarding current trading prices, PCRBF is priced at $0.36, while BYDIF trades at $3.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas BYDIF's P/E ratio is 14.87. In terms of profitability, PCRBF's ROE is +0.01%, compared to BYDIF's ROE of +0.10%. Regarding short-term risk, PCRBF is less volatile compared to BYDIF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check BYDIF's competition here
PCRBF vs SNPTF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, SNPTF has a market cap of 7.5B. Regarding current trading prices, PCRBF is priced at $0.36, while SNPTF trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas SNPTF's P/E ratio is 11.11. In terms of profitability, PCRBF's ROE is +0.01%, compared to SNPTF's ROE of +0.17%. Regarding short-term risk, PCRBF and SNPTF have similar daily volatility (0.00).Check SNPTF's competition here
PCRBF vs FITGF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, FITGF has a market cap of 7.3B. Regarding current trading prices, PCRBF is priced at $0.36, while FITGF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas FITGF's P/E ratio is 51.00. In terms of profitability, PCRBF's ROE is +0.01%, compared to FITGF's ROE of +0.06%. Regarding short-term risk, PCRBF is less volatile compared to FITGF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check FITGF's competition here
PCRBF vs SHMZF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, SHMZF has a market cap of 7.1B. Regarding current trading prices, PCRBF is priced at $0.36, while SHMZF trades at $24.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas SHMZF's P/E ratio is 18.69. In terms of profitability, PCRBF's ROE is +0.01%, compared to SHMZF's ROE of +0.12%. Regarding short-term risk, PCRBF is less volatile compared to SHMZF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check SHMZF's competition here
PCRBF vs OMRNY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, OMRNY has a market cap of 6.9B. Regarding current trading prices, PCRBF is priced at $0.36, while OMRNY trades at $34.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas OMRNY's P/E ratio is 32.23. In terms of profitability, PCRBF's ROE is +0.01%, compared to OMRNY's ROE of +0.04%. Regarding short-term risk, PCRBF is less volatile compared to OMRNY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check OMRNY's competition here
PCRBF vs HRIBF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, HRIBF has a market cap of 6.9B. Regarding current trading prices, PCRBF is priced at $0.36, while HRIBF trades at $163.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas HRIBF's P/E ratio is 29.81. In terms of profitability, PCRBF's ROE is +0.01%, compared to HRIBF's ROE of +0.11%. Regarding short-term risk, PCRBF is less volatile compared to HRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check HRIBF's competition here
PCRBF vs HROEY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, HROEY has a market cap of 5.7B. Regarding current trading prices, PCRBF is priced at $0.36, while HROEY trades at $17.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas HROEY's P/E ratio is 28.18. In terms of profitability, PCRBF's ROE is +0.01%, compared to HROEY's ROE of +0.09%. Regarding short-term risk, PCRBF and HROEY have similar daily volatility (0.00).Check HROEY's competition here
PCRBF vs AUOTY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, AUOTY has a market cap of 5.6B. Regarding current trading prices, PCRBF is priced at $0.36, while AUOTY trades at $7.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas AUOTY's P/E ratio is 25.45. In terms of profitability, PCRBF's ROE is +0.01%, compared to AUOTY's ROE of +0.02%. Regarding short-term risk, PCRBF is less volatile compared to AUOTY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check AUOTY's competition here
PCRBF vs HRSEF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, HRSEF has a market cap of 5.3B. Regarding current trading prices, PCRBF is priced at $0.36, while HRSEF trades at $162.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas HRSEF's P/E ratio is 27.10. In terms of profitability, PCRBF's ROE is +0.01%, compared to HRSEF's ROE of +0.09%. Regarding short-term risk, PCRBF and HRSEF have similar daily volatility (0.00).Check HRSEF's competition here
PCRBF vs RNSHF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, RNSHF has a market cap of 5.3B. Regarding current trading prices, PCRBF is priced at $0.36, while RNSHF trades at $68.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas RNSHF's P/E ratio is 53.28. In terms of profitability, PCRBF's ROE is +0.01%, compared to RNSHF's ROE of +0.08%. Regarding short-term risk, PCRBF and RNSHF have similar daily volatility (0.00).Check RNSHF's competition here
PCRBF vs SEPJF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, SEPJF has a market cap of 5.2B. Regarding current trading prices, PCRBF is priced at $0.36, while SEPJF trades at $52.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas SEPJF's P/E ratio is 67.55. In terms of profitability, PCRBF's ROE is +0.01%, compared to SEPJF's ROE of +0.04%. Regarding short-term risk, PCRBF is less volatile compared to SEPJF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check SEPJF's competition here
PCRBF vs HPHTY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, HPHTY has a market cap of 4.7B. Regarding current trading prices, PCRBF is priced at $0.36, while HPHTY trades at $8.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas HPHTY's P/E ratio is 57.96. In terms of profitability, PCRBF's ROE is +0.01%, compared to HPHTY's ROE of +0.04%. Regarding short-term risk, PCRBF is less volatile compared to HPHTY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check HPHTY's competition here
PCRBF vs HPHTF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, HPHTF has a market cap of 4.6B. Regarding current trading prices, PCRBF is priced at $0.36, while HPHTF trades at $15.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas HPHTF's P/E ratio is 56.86. In terms of profitability, PCRBF's ROE is +0.01%, compared to HPHTF's ROE of +0.04%. Regarding short-term risk, PCRBF is less volatile compared to HPHTF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check HPHTF's competition here
PCRBF vs CODAF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, CODAF has a market cap of 4.3B. Regarding current trading prices, PCRBF is priced at $0.36, while CODAF trades at $23.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas CODAF's P/E ratio is 47.22. In terms of profitability, PCRBF's ROE is +0.01%, compared to CODAF's ROE of +0.24%. Regarding short-term risk, PCRBF and CODAF have similar daily volatility (0.00).Check CODAF's competition here
PCRBF vs VEMLF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, VEMLF has a market cap of 4B. Regarding current trading prices, PCRBF is priced at $0.36, while VEMLF trades at $13.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas VEMLF's P/E ratio is 22.93. In terms of profitability, PCRBF's ROE is +0.01%, compared to VEMLF's ROE of +0.06%. Regarding short-term risk, PCRBF and VEMLF have similar daily volatility (0.00).Check VEMLF's competition here
PCRBF vs NPEGF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, NPEGF has a market cap of 3.1B. Regarding current trading prices, PCRBF is priced at $0.36, while NPEGF trades at $36.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas NPEGF's P/E ratio is 17.67. In terms of profitability, PCRBF's ROE is +0.01%, compared to NPEGF's ROE of +0.07%. Regarding short-term risk, PCRBF and NPEGF have similar daily volatility (0.00).Check NPEGF's competition here
PCRBF vs JNPKF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, JNPKF has a market cap of 2.8B. Regarding current trading prices, PCRBF is priced at $0.36, while JNPKF trades at $49.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas JNPKF's P/E ratio is 36.06. In terms of profitability, PCRBF's ROE is +0.01%, compared to JNPKF's ROE of +0.08%. Regarding short-term risk, PCRBF and JNPKF have similar daily volatility (0.00).Check JNPKF's competition here
PCRBF vs APELY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, APELY has a market cap of 2.6B. Regarding current trading prices, PCRBF is priced at $0.36, while APELY trades at $25.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas APELY's P/E ratio is 15.82. In terms of profitability, PCRBF's ROE is +0.01%, compared to APELY's ROE of +0.06%. Regarding short-term risk, PCRBF and APELY have similar daily volatility (0.00).Check APELY's competition here
PCRBF vs SEPJY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, SEPJY has a market cap of 2.6B. Regarding current trading prices, PCRBF is priced at $0.36, while SEPJY trades at $25.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas SEPJY's P/E ratio is 67.63. In terms of profitability, PCRBF's ROE is +0.01%, compared to SEPJY's ROE of +0.04%. Regarding short-term risk, PCRBF and SEPJY have similar daily volatility (0.00).Check SEPJY's competition here
PCRBF vs VAIAF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, VAIAF has a market cap of 2.4B. Regarding current trading prices, PCRBF is priced at $0.36, while VAIAF trades at $60.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas VAIAF's P/E ratio is 30.82. In terms of profitability, PCRBF's ROE is +0.01%, compared to VAIAF's ROE of +0.20%. Regarding short-term risk, PCRBF and VAIAF have similar daily volatility (0.00).Check VAIAF's competition here
PCRBF vs TOPCF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, TOPCF has a market cap of 2.2B. Regarding current trading prices, PCRBF is priced at $0.36, while TOPCF trades at $21.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas TOPCF's P/E ratio is -0.00. In terms of profitability, PCRBF's ROE is +0.01%, compared to TOPCF's ROE of -0.13%. Regarding short-term risk, PCRBF and TOPCF have similar daily volatility (0.00).Check TOPCF's competition here
PCRBF vs AITUY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, AITUY has a market cap of 2B. Regarding current trading prices, PCRBF is priced at $0.36, while AITUY trades at $15.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas AITUY's P/E ratio is 28.77. In terms of profitability, PCRBF's ROE is +0.01%, compared to AITUY's ROE of +0.09%. Regarding short-term risk, PCRBF and AITUY have similar daily volatility (0.00).Check AITUY's competition here
PCRBF vs APELF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, APELF has a market cap of 2B. Regarding current trading prices, PCRBF is priced at $0.36, while APELF trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas APELF's P/E ratio is 8.00. In terms of profitability, PCRBF's ROE is +0.01%, compared to APELF's ROE of +0.08%. Regarding short-term risk, PCRBF and APELF have similar daily volatility (0.00).Check APELF's competition here
PCRBF vs JELLF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, JELLF has a market cap of 1.8B. Regarding current trading prices, PCRBF is priced at $0.36, while JELLF trades at $37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas JELLF's P/E ratio is 17.13. In terms of profitability, PCRBF's ROE is +0.01%, compared to JELLF's ROE of +0.15%. Regarding short-term risk, PCRBF and JELLF have similar daily volatility (0.00).Check JELLF's competition here
PCRBF vs AITUF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, AITUF has a market cap of 1.7B. Regarding current trading prices, PCRBF is priced at $0.36, while AITUF trades at $13.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas AITUF's P/E ratio is 25.79. In terms of profitability, PCRBF's ROE is +0.01%, compared to AITUF's ROE of +0.09%. Regarding short-term risk, PCRBF is less volatile compared to AITUF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check AITUF's competition here
PCRBF vs AMANF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, AMANF has a market cap of 1.7B. Regarding current trading prices, PCRBF is priced at $0.36, while AMANF trades at $25.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas AMANF's P/E ratio is 24.15. In terms of profitability, PCRBF's ROE is +0.01%, compared to AMANF's ROE of +0.15%. Regarding short-term risk, PCRBF and AMANF have similar daily volatility (0.00).Check AMANF's competition here
PCRBF vs KRKNF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, KRKNF has a market cap of 1.6B. Regarding current trading prices, PCRBF is priced at $0.36, while KRKNF trades at $4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas KRKNF's P/E ratio is 515.00. In terms of profitability, PCRBF's ROE is +0.01%, compared to KRKNF's ROE of -0.00%. Regarding short-term risk, PCRBF is less volatile compared to KRKNF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check KRKNF's competition here
PCRBF vs NILRF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, NILRF has a market cap of 1.5B. Regarding current trading prices, PCRBF is priced at $0.36, while NILRF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas NILRF's P/E ratio is -4.30. In terms of profitability, PCRBF's ROE is +0.01%, compared to NILRF's ROE of N/A. Regarding short-term risk, PCRBF and NILRF have similar daily volatility (0.00).Check NILRF's competition here
PCRBF vs JNNDF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, JNNDF has a market cap of 1.5B. Regarding current trading prices, PCRBF is priced at $0.36, while JNNDF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas JNNDF's P/E ratio is -18.69. In terms of profitability, PCRBF's ROE is +0.01%, compared to JNNDF's ROE of +2.98%. Regarding short-term risk, PCRBF and JNNDF have similar daily volatility (0.00).Check JNNDF's competition here
PCRBF vs JPDYY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, JPDYY has a market cap of 1.4B. Regarding current trading prices, PCRBF is priced at $0.36, while JPDYY trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas JPDYY's P/E ratio is -18.35. In terms of profitability, PCRBF's ROE is +0.01%, compared to JPDYY's ROE of +2.75%. Regarding short-term risk, PCRBF and JPDYY have similar daily volatility (0.00).Check JPDYY's competition here
PCRBF vs JPAVF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, JPAVF has a market cap of 915.7M. Regarding current trading prices, PCRBF is priced at $0.36, while JPAVF trades at $13.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas JPAVF's P/E ratio is 20.58. In terms of profitability, PCRBF's ROE is +0.01%, compared to JPAVF's ROE of +0.05%. Regarding short-term risk, PCRBF and JPAVF have similar daily volatility (0.00).Check JPAVF's competition here
PCRBF vs CAZGF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, CAZGF has a market cap of 883.7M. Regarding current trading prices, PCRBF is priced at $0.36, while CAZGF trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas CAZGF's P/E ratio is -22.00. In terms of profitability, PCRBF's ROE is +0.01%, compared to CAZGF's ROE of -0.21%. Regarding short-term risk, PCRBF and CAZGF have similar daily volatility (0.00).Check CAZGF's competition here
PCRBF vs BCNAF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, BCNAF has a market cap of 854.6M. Regarding current trading prices, PCRBF is priced at $0.36, while BCNAF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas BCNAF's P/E ratio is 10.61. In terms of profitability, PCRBF's ROE is +0.01%, compared to BCNAF's ROE of +0.10%. Regarding short-term risk, PCRBF is less volatile compared to BCNAF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check BCNAF's competition here
PCRBF vs KACPF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, KACPF has a market cap of 635M. Regarding current trading prices, PCRBF is priced at $0.36, while KACPF trades at $17.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas KACPF's P/E ratio is 25.52. In terms of profitability, PCRBF's ROE is +0.01%, compared to KACPF's ROE of +0.05%. Regarding short-term risk, PCRBF and KACPF have similar daily volatility (0.00).Check KACPF's competition here
PCRBF vs SMOPF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, SMOPF has a market cap of 554M. Regarding current trading prices, PCRBF is priced at $0.36, while SMOPF trades at $5.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas SMOPF's P/E ratio is 113.00. In terms of profitability, PCRBF's ROE is +0.01%, compared to SMOPF's ROE of +0.17%. Regarding short-term risk, PCRBF is less volatile compared to SMOPF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check SMOPF's competition here
PCRBF vs HNMUF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, HNMUF has a market cap of 517.2M. Regarding current trading prices, PCRBF is priced at $0.36, while HNMUF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas HNMUF's P/E ratio is 112.00. In terms of profitability, PCRBF's ROE is +0.01%, compared to HNMUF's ROE of +0.01%. Regarding short-term risk, PCRBF is less volatile compared to HNMUF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check HNMUF's competition here
PCRBF vs VARXF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, VARXF has a market cap of 488.9M. Regarding current trading prices, PCRBF is priced at $0.36, while VARXF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas VARXF's P/E ratio is 10.57. In terms of profitability, PCRBF's ROE is +0.01%, compared to VARXF's ROE of +0.07%. Regarding short-term risk, PCRBF and VARXF have similar daily volatility (0.00).Check VARXF's competition here
PCRBF vs NNFTF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, NNFTF has a market cap of 325.2M. Regarding current trading prices, PCRBF is priced at $0.36, while NNFTF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas NNFTF's P/E ratio is 49.83. In terms of profitability, PCRBF's ROE is +0.01%, compared to NNFTF's ROE of +0.03%. Regarding short-term risk, PCRBF is less volatile compared to NNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check NNFTF's competition here
PCRBF vs TRUHF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, TRUHF has a market cap of 306.4M. Regarding current trading prices, PCRBF is priced at $0.36, while TRUHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas TRUHF's P/E ratio is 10.40. In terms of profitability, PCRBF's ROE is +0.01%, compared to TRUHF's ROE of +0.03%. Regarding short-term risk, PCRBF and TRUHF have similar daily volatility (0.00).Check TRUHF's competition here
PCRBF vs TTGPF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, TTGPF has a market cap of 281.8M. Regarding current trading prices, PCRBF is priced at $0.36, while TTGPF trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas TTGPF's P/E ratio is -4.16. In terms of profitability, PCRBF's ROE is +0.01%, compared to TTGPF's ROE of -0.31%. Regarding short-term risk, PCRBF and TTGPF have similar daily volatility (0.00).Check TTGPF's competition here
PCRBF vs CHAEF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, CHAEF has a market cap of 266.9M. Regarding current trading prices, PCRBF is priced at $0.36, while CHAEF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas CHAEF's P/E ratio is -8.65. In terms of profitability, PCRBF's ROE is +0.01%, compared to CHAEF's ROE of -0.02%. Regarding short-term risk, PCRBF and CHAEF have similar daily volatility (0.00).Check CHAEF's competition here
PCRBF vs BCNAY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, BCNAY has a market cap of 265M. Regarding current trading prices, PCRBF is priced at $0.36, while BCNAY trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas BCNAY's P/E ratio is 12.90. In terms of profitability, PCRBF's ROE is +0.01%, compared to BCNAY's ROE of +0.10%. Regarding short-term risk, PCRBF and BCNAY have similar daily volatility (0.00).Check BCNAY's competition here
PCRBF vs NPTSF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, NPTSF has a market cap of 245M. Regarding current trading prices, PCRBF is priced at $0.36, while NPTSF trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas NPTSF's P/E ratio is -12.33. In terms of profitability, PCRBF's ROE is +0.01%, compared to NPTSF's ROE of N/A. Regarding short-term risk, PCRBF and NPTSF have similar daily volatility (0.00).Check NPTSF's competition here
PCRBF vs ENMPF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, ENMPF has a market cap of 241.9M. Regarding current trading prices, PCRBF is priced at $0.36, while ENMPF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas ENMPF's P/E ratio is -6.22. In terms of profitability, PCRBF's ROE is +0.01%, compared to ENMPF's ROE of -2.24%. Regarding short-term risk, PCRBF and ENMPF have similar daily volatility (0.00).Check ENMPF's competition here
PCRBF vs AFGYF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, AFGYF has a market cap of 220.5M. Regarding current trading prices, PCRBF is priced at $0.36, while AFGYF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas AFGYF's P/E ratio is -6.47. In terms of profitability, PCRBF's ROE is +0.01%, compared to AFGYF's ROE of -0.77%. Regarding short-term risk, PCRBF and AFGYF have similar daily volatility (0.00).Check AFGYF's competition here
PCRBF vs FUBAF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, FUBAF has a market cap of 164.1M. Regarding current trading prices, PCRBF is priced at $0.36, while FUBAF trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas FUBAF's P/E ratio is 96.75. In terms of profitability, PCRBF's ROE is +0.01%, compared to FUBAF's ROE of +0.04%. Regarding short-term risk, PCRBF and FUBAF have similar daily volatility (0.00).Check FUBAF's competition here
PCRBF vs AUDGF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, AUDGF has a market cap of 147.6M. Regarding current trading prices, PCRBF is priced at $0.36, while AUDGF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas AUDGF's P/E ratio is -13.46. In terms of profitability, PCRBF's ROE is +0.01%, compared to AUDGF's ROE of -0.09%. Regarding short-term risk, PCRBF and AUDGF have similar daily volatility (0.00).Check AUDGF's competition here
PCRBF vs HUDLF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, HUDLF has a market cap of 122.5M. Regarding current trading prices, PCRBF is priced at $0.36, while HUDLF trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas HUDLF's P/E ratio is -18.39. In terms of profitability, PCRBF's ROE is +0.01%, compared to HUDLF's ROE of N/A. Regarding short-term risk, PCRBF and HUDLF have similar daily volatility (0.00).Check HUDLF's competition here
PCRBF vs SDIIF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, SDIIF has a market cap of 109.8M. Regarding current trading prices, PCRBF is priced at $0.36, while SDIIF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas SDIIF's P/E ratio is 17.50. In terms of profitability, PCRBF's ROE is +0.01%, compared to SDIIF's ROE of +0.09%. Regarding short-term risk, PCRBF and SDIIF have similar daily volatility (0.00).Check SDIIF's competition here
PCRBF vs IACYF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, IACYF has a market cap of 108.7M. Regarding current trading prices, PCRBF is priced at $0.36, while IACYF trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas IACYF's P/E ratio is 48.68. In terms of profitability, PCRBF's ROE is +0.01%, compared to IACYF's ROE of +0.05%. Regarding short-term risk, PCRBF is less volatile compared to IACYF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check IACYF's competition here
PCRBF vs IKGPF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, IKGPF has a market cap of 88.5M. Regarding current trading prices, PCRBF is priced at $0.36, while IKGPF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas IKGPF's P/E ratio is -15.67. In terms of profitability, PCRBF's ROE is +0.01%, compared to IKGPF's ROE of -0.56%. Regarding short-term risk, PCRBF and IKGPF have similar daily volatility (0.00).Check IKGPF's competition here
PCRBF vs ENMPY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, ENMPY has a market cap of 64.3M. Regarding current trading prices, PCRBF is priced at $0.36, while ENMPY trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas ENMPY's P/E ratio is -6.63. In terms of profitability, PCRBF's ROE is +0.01%, compared to ENMPY's ROE of -2.87%. Regarding short-term risk, PCRBF is less volatile compared to ENMPY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check ENMPY's competition here
PCRBF vs SILLF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, SILLF has a market cap of 56.6M. Regarding current trading prices, PCRBF is priced at $0.36, while SILLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas SILLF's P/E ratio is -16.60. In terms of profitability, PCRBF's ROE is +0.01%, compared to SILLF's ROE of -0.00%. Regarding short-term risk, PCRBF and SILLF have similar daily volatility (0.00).Check SILLF's competition here
PCRBF vs MPAD Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, MPAD has a market cap of 51.5M. Regarding current trading prices, PCRBF is priced at $0.36, while MPAD trades at $19.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas MPAD's P/E ratio is 10.56. In terms of profitability, PCRBF's ROE is +0.01%, compared to MPAD's ROE of +0.02%. Regarding short-term risk, PCRBF is less volatile compared to MPAD. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check MPAD's competition here
PCRBF vs USPCY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, USPCY has a market cap of 49.5M. Regarding current trading prices, PCRBF is priced at $0.36, while USPCY trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas USPCY's P/E ratio is -1.24. In terms of profitability, PCRBF's ROE is +0.01%, compared to USPCY's ROE of -7.70%. Regarding short-term risk, PCRBF and USPCY have similar daily volatility (0.00).Check USPCY's competition here
PCRBF vs IEHC Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, IEHC has a market cap of 48.5M. Regarding current trading prices, PCRBF is priced at $0.36, while IEHC trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas IEHC's P/E ratio is -52.47. In terms of profitability, PCRBF's ROE is +0.01%, compared to IEHC's ROE of -1.22%. Regarding short-term risk, PCRBF is less volatile compared to IEHC. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check IEHC's competition here
PCRBF vs AATC Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, AATC has a market cap of 29.3M. Regarding current trading prices, PCRBF is priced at $0.36, while AATC trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas AATC's P/E ratio is 5.97. In terms of profitability, PCRBF's ROE is +0.01%, compared to AATC's ROE of +0.13%. Regarding short-term risk, PCRBF is less volatile compared to AATC. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check AATC's competition here
PCRBF vs ERMG Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, ERMG has a market cap of 22.6M. Regarding current trading prices, PCRBF is priced at $0.36, while ERMG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas ERMG's P/E ratio is N/A. In terms of profitability, PCRBF's ROE is +0.01%, compared to ERMG's ROE of +1.16%. Regarding short-term risk, PCRBF and ERMG have similar daily volatility (0.00).Check ERMG's competition here
PCRBF vs INRD Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, INRD has a market cap of 18.3M. Regarding current trading prices, PCRBF is priced at $0.36, while INRD trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas INRD's P/E ratio is 5.19. In terms of profitability, PCRBF's ROE is +0.01%, compared to INRD's ROE of +0.52%. Regarding short-term risk, PCRBF is less volatile compared to INRD. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check INRD's competition here
PCRBF vs KESPF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, KESPF has a market cap of 15.3M. Regarding current trading prices, PCRBF is priced at $0.36, while KESPF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas KESPF's P/E ratio is -1.60. In terms of profitability, PCRBF's ROE is +0.01%, compared to KESPF's ROE of N/A. Regarding short-term risk, PCRBF and KESPF have similar daily volatility (0.00).Check KESPF's competition here
PCRBF vs FGRRF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, FGRRF has a market cap of 15.2M. Regarding current trading prices, PCRBF is priced at $0.36, while FGRRF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas FGRRF's P/E ratio is -200.00. In terms of profitability, PCRBF's ROE is +0.01%, compared to FGRRF's ROE of -0.46%. Regarding short-term risk, PCRBF and FGRRF have similar daily volatility (0.00).Check FGRRF's competition here
PCRBF vs WELX Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, WELX has a market cap of 13.2M. Regarding current trading prices, PCRBF is priced at $0.36, while WELX trades at $2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas WELX's P/E ratio is 18.57. In terms of profitability, PCRBF's ROE is +0.01%, compared to WELX's ROE of -0.21%. Regarding short-term risk, PCRBF is less volatile compared to WELX. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check WELX's competition here
PCRBF vs BNSOF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, BNSOF has a market cap of 11.8M. Regarding current trading prices, PCRBF is priced at $0.36, while BNSOF trades at $2.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas BNSOF's P/E ratio is -4.76. In terms of profitability, PCRBF's ROE is +0.01%, compared to BNSOF's ROE of -0.15%. Regarding short-term risk, PCRBF is less volatile compared to BNSOF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check BNSOF's competition here
PCRBF vs NSCIF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, NSCIF has a market cap of 10.7M. Regarding current trading prices, PCRBF is priced at $0.36, while NSCIF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas NSCIF's P/E ratio is -2.34. In terms of profitability, PCRBF's ROE is +0.01%, compared to NSCIF's ROE of -0.45%. Regarding short-term risk, PCRBF and NSCIF have similar daily volatility (0.00).Check NSCIF's competition here
PCRBF vs ZTSTF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, ZTSTF has a market cap of 9.4M. Regarding current trading prices, PCRBF is priced at $0.36, while ZTSTF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas ZTSTF's P/E ratio is 8.50. In terms of profitability, PCRBF's ROE is +0.01%, compared to ZTSTF's ROE of +0.21%. Regarding short-term risk, PCRBF is less volatile compared to ZTSTF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check ZTSTF's competition here
PCRBF vs YNVYF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, YNVYF has a market cap of 9.2M. Regarding current trading prices, PCRBF is priced at $0.36, while YNVYF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas YNVYF's P/E ratio is -1.45. In terms of profitability, PCRBF's ROE is +0.01%, compared to YNVYF's ROE of -2.69%. Regarding short-term risk, PCRBF and YNVYF have similar daily volatility (0.00).Check YNVYF's competition here
PCRBF vs TKOI Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, TKOI has a market cap of 8.6M. Regarding current trading prices, PCRBF is priced at $0.36, while TKOI trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas TKOI's P/E ratio is -0.48. In terms of profitability, PCRBF's ROE is +0.01%, compared to TKOI's ROE of -0.34%. Regarding short-term risk, PCRBF is less volatile compared to TKOI. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check TKOI's competition here
PCRBF vs SCND Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, SCND has a market cap of 8.4M. Regarding current trading prices, PCRBF is priced at $0.36, while SCND trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas SCND's P/E ratio is -7.00. In terms of profitability, PCRBF's ROE is +0.01%, compared to SCND's ROE of -0.10%. Regarding short-term risk, PCRBF and SCND have similar daily volatility (0.00).Check SCND's competition here
PCRBF vs ROBOF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, ROBOF has a market cap of 6.5M. Regarding current trading prices, PCRBF is priced at $0.36, while ROBOF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas ROBOF's P/E ratio is -11.00. In terms of profitability, PCRBF's ROE is +0.01%, compared to ROBOF's ROE of -0.72%. Regarding short-term risk, PCRBF is less volatile compared to ROBOF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check ROBOF's competition here
PCRBF vs LCTC Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, LCTC has a market cap of 5.9M. Regarding current trading prices, PCRBF is priced at $0.36, while LCTC trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas LCTC's P/E ratio is -2.54. In terms of profitability, PCRBF's ROE is +0.01%, compared to LCTC's ROE of -0.48%. Regarding short-term risk, PCRBF and LCTC have similar daily volatility (0.00).Check LCTC's competition here
PCRBF vs SIGL Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, SIGL has a market cap of 5.8M. Regarding current trading prices, PCRBF is priced at $0.36, while SIGL trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas SIGL's P/E ratio is -15.00. In terms of profitability, PCRBF's ROE is +0.01%, compared to SIGL's ROE of -0.29%. Regarding short-term risk, PCRBF and SIGL have similar daily volatility (0.00).Check SIGL's competition here
PCRBF vs VIAOY Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, VIAOY has a market cap of 5.7M. Regarding current trading prices, PCRBF is priced at $0.36, while VIAOY trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas VIAOY's P/E ratio is -0.09. In terms of profitability, PCRBF's ROE is +0.01%, compared to VIAOY's ROE of -0.18%. Regarding short-term risk, PCRBF and VIAOY have similar daily volatility (0.00).Check VIAOY's competition here
PCRBF vs AAIRF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, AAIRF has a market cap of 5.2M. Regarding current trading prices, PCRBF is priced at $0.36, while AAIRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas AAIRF's P/E ratio is -0.83. In terms of profitability, PCRBF's ROE is +0.01%, compared to AAIRF's ROE of +3.41%. Regarding short-term risk, PCRBF is less volatile compared to AAIRF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check AAIRF's competition here
PCRBF vs TRCK Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, TRCK has a market cap of 4.3M. Regarding current trading prices, PCRBF is priced at $0.36, while TRCK trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas TRCK's P/E ratio is 12.17. In terms of profitability, PCRBF's ROE is +0.01%, compared to TRCK's ROE of -0.04%. Regarding short-term risk, PCRBF is less volatile compared to TRCK. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check TRCK's competition here
PCRBF vs VPIM Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, VPIM has a market cap of 3M. Regarding current trading prices, PCRBF is priced at $0.36, while VPIM trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas VPIM's P/E ratio is N/A. In terms of profitability, PCRBF's ROE is +0.01%, compared to VPIM's ROE of +0.00%. Regarding short-term risk, PCRBF and VPIM have similar daily volatility (0.00).Check VPIM's competition here
PCRBF vs EQTL Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, EQTL has a market cap of 2.7M. Regarding current trading prices, PCRBF is priced at $0.36, while EQTL trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas EQTL's P/E ratio is N/A. In terms of profitability, PCRBF's ROE is +0.01%, compared to EQTL's ROE of N/A. Regarding short-term risk, PCRBF and EQTL have similar daily volatility (0.00).Check EQTL's competition here
PCRBF vs GNCLF Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, GNCLF has a market cap of 2.7M. Regarding current trading prices, PCRBF is priced at $0.36, while GNCLF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas GNCLF's P/E ratio is -0.07. In terms of profitability, PCRBF's ROE is +0.01%, compared to GNCLF's ROE of -0.98%. Regarding short-term risk, PCRBF is less volatile compared to GNCLF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check GNCLF's competition here
PCRBF vs UCLE Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, UCLE has a market cap of 2.5M. Regarding current trading prices, PCRBF is priced at $0.36, while UCLE trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas UCLE's P/E ratio is -1.33. In terms of profitability, PCRBF's ROE is +0.01%, compared to UCLE's ROE of +3.05%. Regarding short-term risk, PCRBF and UCLE have similar daily volatility (0.00).Check UCLE's competition here
PCRBF vs DGNG Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, DGNG has a market cap of 2.3M. Regarding current trading prices, PCRBF is priced at $0.36, while DGNG trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas DGNG's P/E ratio is N/A. In terms of profitability, PCRBF's ROE is +0.01%, compared to DGNG's ROE of +0.00%. Regarding short-term risk, PCRBF and DGNG have similar daily volatility (0.00).Check DGNG's competition here
PCRBF vs RMTD Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, RMTD has a market cap of 1.5M. Regarding current trading prices, PCRBF is priced at $0.36, while RMTD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas RMTD's P/E ratio is N/A. In terms of profitability, PCRBF's ROE is +0.01%, compared to RMTD's ROE of +0.29%. Regarding short-term risk, PCRBF is less volatile compared to RMTD. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check RMTD's competition here
PCRBF vs VPER Comparison June 2026
PCRBF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 58.2M. In comparison, VPER has a market cap of 1.3M. Regarding current trading prices, PCRBF is priced at $0.36, while VPER trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 35.60, whereas VPER's P/E ratio is N/A. In terms of profitability, PCRBF's ROE is +0.01%, compared to VPER's ROE of -0.03%. Regarding short-term risk, PCRBF is less volatile compared to VPER. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check VPER's competition here